Our previous studies confirmed that the expression of CD276 is higher in ccRCC tumor tissues than in normal adjacent tissues, indicating its role as a molecular marker for diagnosing ccRCC.13, 14. The gene discussed is CD276; the disease is nonpapillary renal cell carcinoma.